Guardant Health, Inc., a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening is now covered for eligible UnitedHealth Group members 1, making it ...
GlobalData on MSN
Labcorp announces colorectal cancer test availability in US
ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
Grail is awaiting an FDA ruling on a cancer screening test, but already more tests are finding their way into medical ...
The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...
Everyone thinks they know their bodies well enough to detect if something were off. But some cancers fly under the radar, so simply knowing your body isn't always enough when it comes to your health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results